Recommended Topic Related To:

Kerlone

"Dec. 14, 2012 -- Drinking a glass of beet juice may have an immediate impact on lowering blood pressure, according to a new study.

The study shows that within hours of drinking it, beet juice lowered systolic blood pressure (the top n"...

Kerlone

Indications
Dosage
How Supplied

INDICATIONS

Kerlone (betaxolol hydrochloride) is indicated in the management of hypertension. It may be used alone or concomitantly with other antihypertensive agents, particularly thiazide-type diuretics.

DOSAGE AND ADMINISTRATION

The initial dose of Kerlone (betaxolol hydrochloride) in hypertension is ordinarily 10 mg once daily either alone or added to diuretic therapy. The full antihypertensive effect is usually seen within 7 to 14 days. If the desired response is not achieved the dose can be doubled after 7 to 14 days. Increasing the dose beyond 20 mg has not been shown to produce a statistically significant additional antihypertensive effect; but the 40-mg dose has been studied and is well tolerated. An increased effect (reduction) on heart rate should be anticipated with increasing dosage. If monotherapy with Kerlone (betaxolol hydrochloride) does not produce the desired response, the addition of a diuretic agent or other antihypertensive should be considered (see, DRUG INTERACTIONS).

Dosage adjustments for specific patients

Patients with renal failure: In patients with renal impairment, clearance of betaxolol declines with decreasing renal function.

In patients with severe renal impairment and those undergoing dialysis the initial dose of Kerlone (betaxolol hydrochloride) is 5 mg once daily. If the desired response is not achieved, dosage may be increased by 5 mg/day increments every 2 weeks to a maximum dose of 20 mg/day.

Patients with hepatic disease: Patients with hepatic disease do not have significantly altered clearance. Dosage adjustments are not routinely needed.

Elderly patients: Consideration should be given to reduction in the starting dose to 5 mg in elderly patients. These patients are especially prone to beta-blocker-induced bradycardia, which appears to be dose related and sometimes responds to reductions in dose.

Cessation of therapy: If withdrawal of Kerlone (betaxolol hydrochloride) therapy is planned, it should be achieved gradually over a period of about 2 weeks. Patients should be carefully observed and advised to limit physical activity to a minimum.

HOW SUPPLIED

Kerlone (betaxolol hydrochloride) 10-mg tablets are round, white, film coated, with KERLONE (betaxolol hydrochloride) 10 debossed on one side and scored on the other, supplied as:

NDC Number Size
0025-5101-31 bottle of 100

Kerlone (betaxolol hydrochloride) 20-mg tablets are round, white, film coated, with KERLONE (betaxolol hydrochloride) 20 debossed on one side and β on the other, supplied as:

NDC Number Size
0025-5201-31 bottle of 100

Store at controlled room temperature 15° - 25°C (59° - 77°F)

Manufactured for: sanofi-aventis U.S. LLC Bridgewater, NJ 08807. Revised September 2008.

Last reviewed on RxList: 7/28/2009
This monograph has been modified to include the generic and brand name in many instances.

Indications
Dosage
How Supplied
A A A

Kerlone - User Reviews

Kerlone User Reviews

Now you can gain knowledge and insight about a drug treatment with Patient Discussions.

Here is a collection of user reviews for the medication Kerlone sorted by most helpful. Patient Discussions FAQs

Report Problems to the Food and Drug Administration

 

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.


Hypertension

Get tips on handling your hypertension.


NIH talks about Ebola on WebMD